GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Grey Wolf Animal Health Corp (TSXV:WOLF) » Definitions » Intangible Assets

Grey Wolf Animal Health (TSXV:WOLF) Intangible Assets : C$22.68 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Grey Wolf Animal Health Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Grey Wolf Animal Health's intangible assets for the quarter that ended in Sep. 2024 was C$22.68 Mil.


Grey Wolf Animal Health Intangible Assets Historical Data

The historical data trend for Grey Wolf Animal Health's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grey Wolf Animal Health Intangible Assets Chart

Grey Wolf Animal Health Annual Data
Trend Dec21 Dec22 Dec23
Intangible Assets
25.47 24.39 23.41

Grey Wolf Animal Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.66 23.41 23.17 22.93 22.68

Grey Wolf Animal Health Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Grey Wolf Animal Health  (TSXV:WOLF) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Grey Wolf Animal Health Intangible Assets Related Terms

Thank you for viewing the detailed overview of Grey Wolf Animal Health's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Grey Wolf Animal Health Business Description

Traded in Other Exchanges
N/A
Address
100 King Street West, Suite 6000, 1 First Canadian Place,, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp operates as an animal health company. It focuses on improving the lives and well-being of vets and pets in Canada. It has two reportable operating segments: the Animal Health business unit selling, marketing, and distributing pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada. and the Pharmacy business unit compounds pharmaceuticals, for equine use but also the bio-identical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients.
Executives
Angela Cechetto Senior Officer
Diane Bourassa Director
Shawn Douglas Aspden Director
Jill Terilee Angevine Director